These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21084033)

  • 1. Excessive medical information increase in package inserts.
    Fuchs J; Werner S; Scheunpflug C; Götze EA; Elstermann K; Scheffel K; Domnowski A; Peter G; Hertzsch C; Hippius M
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):781-90. PubMed ID: 21084033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate dosage instructions in package inserts.
    Fuchs J; Hippius M
    Patient Educ Couns; 2007 Jul; 67(1-2):157-68. PubMed ID: 17451909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug package inserts--varying information for the same medicines].
    Storflor JG; Pettersen LC; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2013 May; 133(9):955-9. PubMed ID: 23652143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 30-year history of the change in package insert for Japanese pharmaceutical medicines].
    Sasaki K; Kondo T
    Yakushigaku Zasshi; 2004; 39(2):276-85. PubMed ID: 16025649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research on Insufficient Information for Pharmaceutical Products].
    Tomita T
    Yakugaku Zasshi; 2017; 137(12):1497-1504. PubMed ID: 29199258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicine package inserts from the users' perspective: are they read and understood?
    Pizzol TDSD; Moraes CG; Arrais PSD; Bertoldi AD; Ramos LR; Farias MR; Oliveira MA; Tavares NUL; Luiza VL; Mengue SS
    Rev Bras Epidemiol; 2019 Mar; 22():e190009. PubMed ID: 30892472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The development and operation of a package inserts service system for electronic medical records].
    Yamada H; Nishimura S; Shimamori Y; Sato S; Hayase Y
    Yakugaku Zasshi; 2003 Mar; 123(3):201-9. PubMed ID: 12693022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the boxed warnings in package inserts of prescription medicines for medical professionals in Japan.
    Mino Y; Naito T; Ohshiro J; Yamada T; Kawakami J
    Pharm Pract (Granada); 2022; 20(4):2733. PubMed ID: 36793916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists voice their concern over patient package inserts.
    Koncel JA
    Hospitals; 1978 Jul; 52(14):103-4, 106. PubMed ID: 658918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug package inserts and the adequacy of patient's drug information].
    da Silva T; Dal-Pizzol F; Bello CM; Mengue SS; Schenkel EP
    Rev Saude Publica; 2000 Apr; 34(2):184-9. PubMed ID: 10881155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvement of package insert CYP information for prescription drugs marketed in Japan].
    Hirata-Koizumi M; Saito M; Urano T; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):12-8. PubMed ID: 16541745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Information Gaps in Package Inserts Cause Insufficient Patient Information on Correct Handling of Transdermal Patches].
    Lampert A; Haefeli WE; Seidling HM
    Dtsch Med Wochenschr; 2019 Mar; 144(5):e36-e41. PubMed ID: 30836398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.
    Gebran N; Al Haidari K
    Ann Saudi Med; 2006; 26(3):192-9. PubMed ID: 16861873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
    Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An examination in comparison Web site with other root on the revised information of drug package insert].
    Okuyama K; Terasawa M; Takahashi T; Yamada Y
    Yakugaku Zasshi; 2005 Aug; 125(8):639-42. PubMed ID: 16079614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the statements in the information on drug metabolizing enzyme in the package insert--the present regulation and its history in Japan, the U.S. and the U.K.
    Watanabe S; Misu T; Kurihara T; Suzuki S; Sakurada T; Satoh N; Ueda S
    Yakushigaku Zasshi; 2008; 43(2):175-80. PubMed ID: 19579828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the comprehension of new rephrasing drug package inserts].
    Miquel AV; Ortín Font F; Marrugat J; Pavesi M
    Med Clin (Barc); 2000 Oct; 115(11):410-7. PubMed ID: 11093843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.